Analysts: U.S. CRO market to grow 9.7% by 2015; In clinical trials, some patients remain unaware of serious side effects;

> The U.S. CRO market will grow about 9.7% by 2015, Research and Markets reports, facing the challenges of mounting outsourcing and a shortage of staff. Release

> Some post-market clinical trials carry significant risk of serious side effects, and, in many cases, physicians aren't required to inform patients. Story

> Bend Research has opened a spray-drying facility, allowing it to work with high-potency ingredients and manufacture APIs for inhaled delivery. News

> Precos got a license to store and handle tissue from the U.K.'s Human Tissue Authority, allowing the company to expand its portfolio of preclinical cancer models. Article

> The European Medicines Agency has recalled a drug manufactured by Pacira ($PCRX) in California, saying it has discovered sterility issues at the company's plant. More

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.